PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32832010-2	2020	Here, we investigate whether direct NLRP3 inflammasome inhibition exerts additive effects on myocardial protection induced by the P2Y12 receptor antagonist Ticagrelor.	Ticagrelor	156-166	NLR family, pyrin domain containing 3	Rattus norvegicus	36-41	
33512659-0	2021	Pretreatment of Indobufen and Aspirin and their Combinations with Clopidogrel or Ticagrelor Alleviates Inflammasome Mediated Pyroptosis Via Inhibiting NF-kappaB/NLRP3 Pathway in Ischemic Stroke.	Ticagrelor	81-91	NLR family, pyrin domain containing 3	Rattus norvegicus	161-166	
33512659-2	2021	In this study, we investigated the protective efficiency of pretreatment of indobufen or aspirin combined with clopidogrel or ticagrelor (IACT) on cerebral ischemic injury via NF-kappaB/NLRP3 pathway.	Ticagrelor	126-136	NLR family, pyrin domain containing 3	Rattus norvegicus	186-191	
32832010-9	2020	Myocardial IR induced the NLRP3 inflammasome complex formation, which was attenuated by either INF pretreatment ex vivo, or by repeated oral treatment with Ticagrelor.	Ticagrelor	156-166	NLR family, pyrin domain containing 3	Rattus norvegicus	26-31	
27830382-4	2016	HYPOTHESIS: Ticagrelor and rosuvastatin have additive effects on myocardial adenosine levels, and therefore, on IS and post-reperfusion activation of the NLRP3-inflammasome.	Ticagrelor	12-22	NLR family, pyrin domain containing 3	Rattus norvegicus	154-159